BIOMAT Database Logo BIOMAT Database Logo

Protective role of foot-and-mouth disease virus antibody in vitro and in vivo in guinea-pigs. 1983

R C Knudsen, and C M Groocock, and A A Andersen

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D010948 Viral Plaque Assay Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE. Bacteriophage Plaque Assay,Assay, Bacteriophage Plaque,Assay, Viral Plaque,Assays, Bacteriophage Plaque,Assays, Viral Plaque,Bacteriophage Plaque Assays,Plaque Assay, Bacteriophage,Plaque Assay, Viral,Plaque Assays, Bacteriophage,Plaque Assays, Viral,Viral Plaque Assays
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D005536 Foot-and-Mouth Disease A highly infectious disease caused by FOOT AND MOUTH DISEASE VIRUS that affects mammals of the ARTIODACTYLA order (CATTLE; SHEEP; GOATS; and PIGS) and is characterized by high fever followed by the appearance of blisters inside the mouth and on the feet. Foot and Mouth Disease,Disease, Foot-and-Mouth,Diseases, Foot-and-Mouth,Foot-and-Mouth Diseases
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

R C Knudsen, and C M Groocock, and A A Andersen
Thermostable negative-marker foot-and-mouth disease virus serotype O induces protective immunity in guinea pigs.
February 2023, Applied microbiology and biotechnology,
R C Knudsen, and C M Groocock, and A A Andersen
Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
June 2017, Applied microbiology and biotechnology,
R C Knudsen, and C M Groocock, and A A Andersen
Foot and mouth disease virus polyepitope protein produced in bacteria and plants induces protective immunity in guinea pigs.
March 2011, Biochemistry. Biokhimiia,
R C Knudsen, and C M Groocock, and A A Andersen
ANTIBODIES PRODUCED BY GUINEA PIGS INFECTED WITH FOOT-AND-MOUTH DISEASE VIRUS.
June 1965, Journal of immunology (Baltimore, Md. : 1950),
R C Knudsen, and C M Groocock, and A A Andersen
T-lymphocyte responses in guinea pigs vaccinated with foot-and-mouth disease virus.
March 1994, Veterinary immunology and immunopathology,
R C Knudsen, and C M Groocock, and A A Andersen
[On the development of myotropic foot-and-mouth disease virus strains in guinea pigs].
November 1964, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale,
R C Knudsen, and C M Groocock, and A A Andersen
Protection of guinea-pigs against foot-and-mouth disease by simultaneous inoculation of sendai virus and inactivated foot-and-mouth disease vaccine.
January 1972, Archiv fur die gesamte Virusforschung,
R C Knudsen, and C M Groocock, and A A Andersen
Immunization of guinea pigs with foot-and-mouth disease virus subjected to photodynamic inactivation.
January 1966, Acta pathologica et microbiologica Scandinavica,
R C Knudsen, and C M Groocock, and A A Andersen
[On testing the efficiency of foot-and-mouth disease hyperimmune serum in guinea pigs by injecting myotropic foot-and-mouth disease virus strains].
July 1965, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B,
R C Knudsen, and C M Groocock, and A A Andersen
A study of the antibodies in guinea pigs infected with foot-and-mouth disease virus.
January 1962, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!